The crystal structure of PR3, a neutrophil serine proteinase antigen of Wegener's granulomatosis antibodies

Journal of Molecular Biology

Volumn 261, Issue 2, 1996, Pages 267-278

  Fujinaga, Masao ^a   Chernaia, Maia M ^a   Halenbeck, Robert ^b   Koths, Kirsten ^b   James, Michael N G ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Elastase; pr3; Serine proteinase; Wegener's granulomatosis; X ray crystallography

Indexed keywords

ALANINE; ANTIBODY; ASPARTIC ACID; AUTOANTIBODY; CHYMOTRYPSIN; DISACCHARIDE; ISOLEUCINE; LEUKOCYTE ELASTASE; SERINE PROTEINASE; VALINE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; COVALENT BOND; CRYSTAL STRUCTURE; CRYSTALLIZATION; ENZYME STRUCTURE; HUMAN; HUMAN CELL; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FOLDING; WEGENER GRANULOMATOSIS;

ANIMALIA;

EID: 0029833222     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1996.0458     Document Type: Article

References (62)

1. Abola, E. E., Bernstein, F. C., Bryant, S. H., Koetzle, T. F. & Weng, J. (1987). Protein Data Bank. In Crystallographic Databases - Information Content, Software Systems, Scientific Applications (Allen, F. H., Bergerhoff, G. & Sievers, R., eds), pp. 107-132, Data Commission of the International Union of Crystallography, Bonn, Cambridge, Chester.
2. Baggiolini, M., Bretz, U., Dewald, B. & Feigenson, M. E. (1978). The polymorphonuclear leukocyte. Agents Actions, 8, 3-10.
3. Bangalore, N., Travis, J., Onunka, V. C., Pohl, J. & Shafer, W. M. (1990). Identification of the primary antimicrobial domains in human neutrophil cathepsin G. J. Biol. Chem. 265, 13584-13588.
4. Bernstein, F. C., Koetzle, T. F., Williams, G. J. B., Meyer, E. F., Jr, Brice, M. D., Rodgers, J. R., Kennard, O., Shimanouchi, T. & Tasumi, M. (1977). The Protein Data Bank: A computer-based archival file for macromolecular structures. J. Mol. Biol. 112, 535-542.
5. Bode, W., Wei, A.-Z., Huber, R., Meyer, E., Travis, J. & Neumann, S. (1986). X-ray crystal structure of the complex of human leukocyte elastase (PMN elastase) and the third domain of the turkey ovomucoid inhibitor. EMBO J. 5, 2453-2458.
6. Bories, D., Raynal, M. C., Solomon, D. H., Darzynkiewicz, Z. & Cayre, Y. E. (1989). Down-regulation of a serine protease, myeloblastin, causes growth arrest and differentiation of promyelocytic leukemia cells. Cell, 59, 959-968.
7. Brubaker, M. J., Groutas, W. C., Hoidal, J. R. & Rao, N. V. (1992). Human neutrophil proteinase 3: mapping of the substrate binding site using peptidyl thiobenzyl esters. Biochem. Biophys. Res. Commun. 188, 1318-1324.
8. Campanelli, D., Detmers, P. A., Nathan, C. F. & Gabay, J. E. (1990). Azurocidin and a homologous serine protease from neutrophils. Differential antimicrobial and proteolytic properties. J. Clin. Invest. 85, 904-915.
9. CCP4 (1994). The CCP4 Suite: Programs for protein crystallography. Acta Crystallog. sect. D, 50, 760-763.
10. Charles, L. A., Caldas, M. L., Falk, R. J., Terrell, R. S. & Jennette, J. C. (1991). Antibodies against granule proteins activate neutrophils in vitro. J. Leuk. Biol. 50, 539-546.
11. Chirino, A. & Israel, M. (1992). Tom/Frodo. 2.9. Pasadena/Edmonton.
12. Csernok, E., Schmitt, W. H., Ernst, M., Bainton, D. F. & Gross, W. L. (1993). Membrane surface proteinase 3 expression and intracytoplasmic immunoglobulin on neutrophils from patients with ANCA-associated vasculitides. Advan. Exp. Med. Biol. 336, 45-50.
13. Dolman, K. M., van de Wiel, B. A., Kam, C. M., Abbink, J. J., Hack, C. E., Sonnenberg, A., Powers, J. C., von dem Borne, A. E. & Goldschmeding, R. (1992). Determination of proteinase 3-alpha 1-antitrypsin complexes in inflammatory fluids. FEBS Letters, 314, 117-121.
14. Dolman, K. M., van de Wiel, B. A., Kam, C. M., Kerrigan, J. E., Hack, C. E., von dem Borne, A. E., Powers, J. C. & Goldschmeding, R. (1993). Proteinase 3: substrate specificity and possible pathogenetic effect of Wegener's granulomatosis autoantibodies (c-ANCA) by dysregulation of the enzyme. Advan. Exp. Med. Biol. 336, 55-60.
15. Engh, R. A. & Huber, R. (1991). Accurate bond and angle parameters for X-ray protein structure refinement. Acta Crystallog. sect. A, 47, 392-400.
16. Falk, R. J. & Jennette, J. C. (1991). Wegener's granulomatosis, systemic vasculitis, and antineutrophil cytoplasmic autoantibodies. Annu. Rev. Med. 42, 459-469.
17. Fujinaga, M. & Read, R. J. (1987). Experiences with a new translation-function program. J. Appl. Crystallog. 20, 517-521.
18. Fujinaga, M., Gros, P. & van Gunsteren, W. F. (1989). Testing the method of crystallographic refinement using molecular dynamics. J. Appl. Crystallog. 22, 1-8.
19. Gabay, J. E. (1994). Antimicrobial proteins with homology to serine proteases. Ciba Fdn Symp. 186, 237-247.
20. Gabay, J. E., Scott, R. W., Campanelli, D., Griffith, J., Wilde, C., Marra, M. N., Seeger, M. & Nathan, C. F. (1989). Antibiotic proteins of human polymorphonuclear leukocytes. Proc. Natl Acad. Sci. USA, 86, 5610-5614.
21. Geysen, H. M., Tainer, J. A., Rodda, S. J., Mason, T. J., Alexander, H., Getzoff, E. D. & Lerner, R. A. (1987). Chemistry of antibody binding to a protein. Science, 235, 1184-1190.
22. Groutas, W. C., Hoidal, J. R., Brubaker, M. J., Stanga, M. A., Venkataraman, R., Gray, B. H. & Rao, N. V. (1990). Inhibitors of human leukocyte proteinase-3. J. Med. Chem. 33, 1085-1087.
23. Gullberg, U., Lindmark, A., Lindgren, G., Persson, A.-M., Nilsson, E. & Olsson, I. (1995). Carboxyl-terminal prodomain-deleted human leukocyte elastase and cathepsin G are efficiently targeted to granules and enzymatically activated in the rat basophilic/mast cell line RBL. J. Biol. Chem. 270, 12912-12918.
24. Hasilik, A. (1992). The early and late processing of lysozomal enzymes: proteolysis and compartmentation. Experientia, 48, 130-151.
25. Heck, L. W., Rostand, K. S., Hunter, F. A. & Bhown, A. (1986). Isolation, characterization, and amino-terminal amino acid sequence analysis of human neutrophil cathepsin G from normal donors. Anal. Biochem. 158, 217-227.
26. Herzberg, O. & Moult, J. (1991). Analysis of the steric strain in the polypeptide backbone of protein molecules. Proteins: Struct. Funct. Genet. 11, 223-229.
27. Higashi, T. (1989). The processing of diffraction data taken on a screenless Weissenberg camera for macromolecular crystallography. J. Appl. Cystallog. 22, 9-18.
28. Higgins, D. G., Bleasby, A. J. & Fuchs, R. (1992). CLUSTAL V: improved software for multiple sequence alignment. CABIOS, 8, 189-191.
29. Hofmann, K. (1994). BOXSHADE. 2.7. Lausanne, Switzerland.
30. Huber, R. & Bode, W. (1978). Structural basis of the activation and action of trypsin. Acc. Chem. Res. 11, 114-121.
31. Jenne, D. E. (1994). Structure of the azurocidin, proteinase 3, and neutrophil elastase genes. Implications for inflammation and vasculitis. Am. J. Resp. Crit. Care Med. 150, S147-S154.
32. Jennette, J. C. & Falk, R. J. (1993). Pathogenic potential of anti-neutrophil cytoplasmic autoantibodies. Advan. Exp. Med. Biol. 336, 7-15.
33. Jones, T. A. (1978). A graphics model building and refinement system for macromolecules. J. Appl. Crystallog. 11, 268-272.
34. Jones, T. A. & Kjeldgaard, M. (1993). O. 5.9. DatONO AB, Uppsala.
35. Kam, C. M., Kerrigan, J. E., Dolman, K. M., Goldschmeding, R., Von dem Borne, A. E. & Powers, J. C. (1992). Substrate and inhibitor studies on proteinase 3. FEBS Letters, 297, 119-123.
36. Kao, R. C., Wehner, N. G., Skubitz, K. M., Gray, B. H. & Hoidal, J. R. (1988). Proteinase 3. A distinct human polymorphonuclear leukocyte proteinase that produces emphysema in hamsters. J. Clin. Invest. 82, 1963-1973.
37. Labbaye, C., Musette, P. & Cayre, Y. E. (1991). Wegener autoantigen and myeloblastin are encoded by a single mRNA. Proc. Natl Acad. Sci. USA, 88, 9253-9256.
38. Laskowski, R. A., MacArthur, M. W., Moss, D. S. & Thornton, J. M. (1993). PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl Crystallog. 26, 283-291.
39. Leszczynski, J. F. & Rose, G. D. (1986). Loops in globular proteins: a novel category of protein secondary structure. Science, 234, 849-855.
40. Ludemann, J., Utecht, B. & Gross, W. L. (1990). Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme. J. Exp. Med. 171, 357-362.
41. McGuire, M. J., Lipsky, P. E. & Thiele, D. L. (1993). Generation of active myeloid and lymphoid granule serine proteases requires processing by the granule thiol protease dipeptidyl peptidase I. J. Biol. Chem. 268, 2458-2467.
42. Milner-White, E., Ross, B. M., Ismail, R., Belhadj-Mostefa, K. & Poet, R. (1988). One type of gamma-turn, rather than the other gives rise to chain-reversal in proteins. J. Mol. Biol. 204, 777-782.
43. Navia, M. A., McKeever, B. M., Springer, J. P., Lin, T. Y., Williams, H. R., Fluder, E. M., Dorn, C. P. & Hoogsteen, K. (1989). Structure of human neutrophil elastase in complex with a peptide chloromethyl ketone inhibitor at 1.84-A resolution. Proc. Natl Acad. Sci. USA, 86, 7-11.
44. Nicholls, A. (1994). GRASP. 1.2. New York.
45. Odeberg, H. & Olsson, I. (1976). Mechanisms for the microbicidal activity of cationic proteins of human granulocytes. Infect. Immun. 14, 1269-1275.
46. Pereira, H. A., Erdem, I., Pohl, J. & Spitznagel, J. K. (1993). Synthetic bactericidal peptide based on CAP37: a 37-kDa human neutrophil granule-associated cationic antimicrobial protein chemotactic for monocytes. Proc. Natl Acad. Sci. USA, 90, 4733-4737.
47. Ramachandran, G. N., Ramakrishnan, C. & Sasisekharan, V. (1963). Stereochemistry of polypeptide chain configurations. J. Mol. Biol. 7, 95-99.
48. Ramakrishnan, C. & Ramachandran, G. N. (1965). Stereochemical criteria for polypeptide and protein chain conformations. II. Allowed conformations for a pair of peptide units. Biophys. J. 5, 909-933.
49. Rao, N. V., Wehner, N. G., Marshall, B. C., Gray, W. R., Gray, B. H. & Hoidal, J. R. (1991). Characterization of proteinase-3 (PR-3), a neutrophil serine proteinase. Structural and functional properties. J. Biol. Chem. 266, 9540-9548.
50. Read, R. J. (1986). Improved Fourier coefficients for maps using phases from partial structures with errors. Acta Crystallog. sect. A, 42, 140-149.
51. Robache-Gallea, S., Morand, V., Bruneau, J. M., Schoot, B., Tagat, E., Réalo, E., Chouaib, S. & Roman-Roman, S. (1995). In vitro processing of human tumor necrosis factor-α. J. Biol. Chem. 270, 23688-23692.
52. Sakabe, N. (1983). A focusing Weissenberg camera with multi-layer-line screens for macromolecular crystalography. J. Appl. Crystallog. 16, 542-547.
53. Salvesen, G. & Enghild, J. J. (1990). An unusual specificity in the activation of neutrophil serine proteinase zymogens. Biochemistry, 29, 5304-5308.
54. Schechter, I. & Berger, A. (1967). On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 27, 157-162.
55. Shafer, W. M., Shepherd, M. E., Boltin, B., Wells, L. & Pohl, J. (1993). Synthetic peptides of human lysosomal cathepsin G with potent antipseudomonal activity. Infect. Immun. 61, 1900-1908.
56. Sinha, S., Watorek, W., Karr, S., Giles, J., Bode, W. & Travis, J. (1987). Primary structure of human neutrophil elastase. Proc. Natl Acad. Sci. USA, 84, 2228-2232.
57. Tronrud, D. E. (1995). The TNT Refinement Package. 5-E. Oregon State Board of Higher Education, Eugene, Oregon.
58. van Gunsteren, W. F. & Berendsen, H. J. C. (1987). GROMOS. Groningen Molecular Simulation Library. BIOMOS b. v., Groningen.
59. Wei, A. Z., Mayr, I. & Bode, W. (1988). The refined 2.3 A crystal structure of human leukocyte elastase in a complex with a valine chloromethyl ketone inhibitor. FEBS Letters, 234, 367-373.
60. Wiedow, O., Luademann, J. & Utecht, B. (1991). Elafin is a potent inhibitor of proteinase 3. Biochem. Biophys. Res. Commun. 174, 6-10.
61. Wilde, C. G., Snable, J. L., Griffith, J. E. & Scott, R. W. (1990). Characterization of two azurophil granule proteases with active-site homology to neutrophil elastase. J. Biol. Chem. 265, 2038-2041.
62. Williams, R. C. J., Staud, R., Malone, C. C., Payabyab, J., Byres, L. & Underwood, D. (1994). Epitopes on proteinase-3 recognized by antibodies from patients with Wegener's granulomatosis. J. Immun. 152, 4722-4737.